Effects of Recombinant Interleukin‐3 and Recombinant Interleukin‐6 on Radiation Survival of Normal Human Bone Marrow Progenitor Cells

The effects of recombinant interleukin-6 (rIL-6) and rIL-3 on the radiation responses of myeloid [colony forming unit-granulocyte-macrophage (CFU-GM)] and erythroid [burst forming unit-erythroid (BFU-E)] human pediatric bone marrow progenitor cells were analyzed. Cytokine exposure times of 30 min, 1 hr, 2 hr, 4 hr, 16 hr, and 24 hr were used prior to irradiation. The most notable observations were based on short exposure data, which provided unprecedented evidence that rIL-6 increases the radiation damage repair capacity of both CFU-GM and BFU-E without affecting their radiation sensitivity, whereas rIL-3 modulated the radiation responses of CFU-GM only. The cytokine-induced increase in radiation survival of CFU-GM or BFU-E at doses ≤200 cGy appeared to be primarily due to an increase in the ability of these hematopoietic progenitor cell populations to repair sublethal radiation damage.

[1]  G. Schieven,et al.  Tyrosine phosphorylation is a mandatory proximal step in radiation-induced activation of the protein kinase C signaling pathway in human B-lymphocyte precursors , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[2]  T Takahashi,et al.  Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. , 1993, Cancer research.

[3]  G. Schieven,et al.  Ionizing radiation stimulates unidentified tyrosine-specific protein kinases in human B-lymphocyte precursors, triggering apoptosis and clonogenic cell death. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[4]  C. Song,et al.  Radiation and heat sensitivity of human T-lineage acute lymphoblastic leukemia (ALL) and acute myeloblastic leukemia (AML) clones displaying multiple drug resistance (MDR). , 1992, International journal of radiation oncology, biology, physics.

[5]  C. Song,et al.  In vitro and in vivo radiation resistance associated with CD3 surface antigen expression in T-lineage acute lymphoblastic leukemia. , 1991, Blood.

[6]  D. Hallahan,et al.  Mechanisms of X-ray-mediated protooncogene c-jun expression in radiation-induced human sarcoma cell lines. , 1991, International journal of radiation oncology, biology, physics.

[7]  C. Song,et al.  Radiation sensitivity of human B-lineage lymphoid precursor cells. , 1991, International journal of radiation oncology, biology, physics.

[8]  C. Song,et al.  Comparative analysis of the in vivo radioprotective effects of recombinant granulocyte colony-stimulating factor (G-CSF), recombinant granulocyte-macrophage CSF, and their combination. , 1991, Blood.

[9]  D. Hallahan,et al.  Protein kinase C mediates x-ray inducibility of nuclear signal transducers EGR1 and JUN. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[10]  N. Nara,et al.  Effects of recombinant human granulocyte colony-stimulating factor on the hematologic recovery and survival of irradiated mice. , 1990, Blood.

[11]  D. Hallahan,et al.  Ionizing radiation regulates expression of the c-jun protooncogene. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. N. Vogel,et al.  In vivo modulation with anti-interleukin-1 (IL-1) receptor (p80) antibody 35F5 of the response to IL-1. The relationship of radioprotection, colony-stimulating factor, and IL-6. , 1990, Blood.

[13]  Y. Shibamoto,et al.  Effect of recombinant human granulocyte colony-stimulating factor on granulocytopenia in mice induced by irradiation. , 1990, International journal of radiation oncology, biology, physics.

[14]  M. Wick,et al.  In vivo radioprotective effects of recombinant human granulocyte colony-stimulating factor in lethally irradiated mice. , 1990, Blood.

[15]  J. Hendry,et al.  The radiosensitivity of human haemopoietic progenitor cells. , 1989, International journal of radiation biology.

[16]  T. Fitzgerald,et al.  Recombinant murine GM-CSF increases resistance of some factor dependent hematopoietic progenitor cells to low-dose-rate gamma irradiation. , 1989, International journal of radiation oncology, biology, physics.

[17]  C. Song,et al.  Effects of recombinant growth factors on radiation survival of human bone marrow progenitor cells. , 1989, International journal of radiation oncology, biology, physics.

[18]  T. Miyamoto,et al.  Radioprotection of C3H mice by recombinant human interleukin-1 alpha. , 1989, International journal of radiation biology.

[19]  J. Ihle,et al.  Synergistic factors for stem cell proliferation: further studies of the target stem cells and the mechanism of stimulation by interleukin-1, interleukin-6, and granulocyte colony-stimulating factor. , 1988, Blood.

[20]  R. Neta,et al.  Cytokines in therapy of radiation injury. , 1988, Blood.

[21]  J. Griffin Clinical applications of colony-stimulating factors. , 1988, Oncology.

[22]  R. Neta,et al.  Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor. , 1988, Journal of immunology.

[23]  R. Neta,et al.  The in vivo effects of interleukin 1. I. Bone marrow cells are induced to cycle after administration of interleukin 1. , 1987, Journal of immunology.

[24]  S. Karlsson,et al.  Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model. , 1987, The Journal of clinical investigation.

[25]  R. Kamen,et al.  The human hematopoietic colony-stimulating factors. , 1987, Science.

[26]  C. Sieff Hematopoietic growth factors. , 1987, The Journal of clinical investigation.

[27]  J. Gabrilove,et al.  Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. , 1986, Science.

[28]  R. Neta,et al.  Interleukin 1 is a radioprotector. , 1986, Journal of immunology.

[29]  D. Metcalf The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. , 1986, Blood.

[30]  F. Uckun,et al.  B lymphocyte regulation of human hematopoiesis. , 1985, Journal of immunology.

[31]  R. Youle,et al.  Combined ex vivo treatment with immunotoxins and mafosfamid: a novel immunochemotherapeutic approach for elimination of neoplastic T cells from autologous marrow grafts. , 1985, Journal of immunology.

[32]  T. Dexter Blood cell development: The message in the medium , 1984, Nature.